Havrilesky, L. J., Lim, S. L., Ehrisman, J. A., Lorenzo, A., Alvarez Secord, A., Yang, J. C., … Reed, S. D. (2019). PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER. In Value in Health (Vol. 22, pp. S541–S541). Elsevier BV. https://doi.org/10.1016/j.jval.2019.09.723

Havrilesky, L. J., S. L. Lim, J. A. Ehrisman, A. Lorenzo, A. Alvarez Secord, J. C. Yang, F. R. Johnson, and S. D. Reed. “PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER.” In Value in Health, 22:S541–S541. Elsevier BV, 2019. https://doi.org/10.1016/j.jval.2019.09.723.

Havrilesky LJ, Lim SL, Ehrisman JA, Lorenzo A, Alvarez Secord A, Yang JC, et al. PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER. In: Value in Health. Elsevier BV; 2019. p. S541–S541.

Havrilesky, L. J., et al. “PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER.” Value in Health, vol. 22, Elsevier BV, 2019, pp. S541–S541. Crossref, doi:10.1016/j.jval.2019.09.723.

Havrilesky LJ, Lim SL, Ehrisman JA, Lorenzo A, Alvarez Secord A, Yang JC, Johnson FR, Reed SD. PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER. Value in Health. Elsevier BV; 2019. p. S541–S541.